🔗 Permalink

Inventor profile of:

Jeffrey Thompson

City:

Stoneham, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2020-03-26

Top Assignees for applications by Jeffrey Thompson

The entities that hold a legal rights for patent applications filed by inventor Thompson Jeffrey:

Biogen Idec MA Inc. 8 Cambridge, MA United States
TOPOTARGET SWITZERLAND SA 4 Lausanne, Switzerland
BIOGEN MA INC. 3 Cambridge, MA United States
Apoxis SA 1 Epalingee, Switzerland
Biogen Idcc MA Inc. 1 Cambridge, MA United States
Apoxis S.A. 1 Epalinges, Switzerland

Recent patent applications by Thompson Jeffrey

Jeffrey Thompson from Stoneham, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-03-26

US20200095305A1

Chemistry; metallurgy

METHODS OF MODULATING IMMUNE RESPONSES USING BCMA POLYPEPTIDE

#2 | 2018-09-27

US20180273605A1

Chemistry; metallurgy

Methods of modulating immune responses using BCMA polypeptide

#3 | 2015-08-06

US20150218247A1

Chemistry; metallurgy

TACI AS AN ANTI-TUMOR AGENT

#4 | 2015-05-21

US20150139992A1

Chemistry; metallurgy

Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA)

#5 | 2015-01-22

US20150023961A1

Chemistry; metallurgy

METHODS OF MODULATING IMMUNOLOGICAL RESPONSES BY ADMINISTERING TRUNCATED BAFF RECEPTORS

#6 | 2013-07-11

US20130177558A1

Chemistry; metallurgy

Method of treating B cell cancers by administering truncated BAFF receptors

#7 | 2012-07-26

US20120189634A1

Chemistry; metallurgy

TACI AS AN ANTI-TUMOR AGENT

#8 | 2011-12-22

US20110311530A1

Chemistry; metallurgy

Method of treating immunological disorders by administering truncated BAFF receptors

#9 | 2010-07-22

US20100184951A1

Chemistry; metallurgy

Truncated BAFF receptors

#10 | 2007-10-02

US10115192

Methods of treating a tumor that expresses APRIL by administering BCMA

#11 | 2006-10-19

US20060234917A1

Chemistry; metallurgy

Truncated baff receptors

#12 | 2006-08-01

US10077438

Methods of treatment by administering an anti-BCMA antibody

InventorID:

334127 ⎘